Early prostate cancer robot surgery preserves over 90% of nerves, accurately treating prostate cancer according to the characteristics of Chinese people | Surgery | Robotics

Release time:Apr 13, 2024 22:14 PM

At the recent 2023 Prostate Cancer Academic Week and Pujiang Prostate Cancer Summit Forum, the Robot Surgery Innovation Center of Shanghai Institute of Urology and Oncology was established. On the same day, the prostate cancer sub specialty team of the Urology Department of Fudan University Affiliated Cancer Hospital, affiliated with the center, released the latest data on robot prostate cancer surgery in the past two years: a single center of the cancer hospital carries out nearly a thousand early prostate cancer robot radical surgeries every year. Thanks to Professor Ye Dingwei's innovative upgraded version of the prostate cancer radical surgery based on the precision robot surgery system, the "Revitalization Technique 2.0", the proportion of patients who receive nerve preserving radical surgery exceeds 90%.

The lifestyle and dietary structure of Chinese residents have changed, and the prevalence of early screening for prostate cancer has been increasing year by year. Experts say that the incidence of prostate cancer in China is gradually becoming younger, and more young patients are being diagnosed early. According to data from cancer hospitals, the proportion of patients under the age of 60 who undergo radical surgery for early prostate cancer increases by 3-4% annually. As patients have just entered middle age, they also have higher requirements for postoperative quality of life.

Radical surgery is the preferred option for prostate cancer patients to achieve a curative effect, but in males, the prostate is adjacent to the sexual nerve, and a slight mistake in the surgery may lead to the loss of sexual function. Intraoperative preservation of nerves is a strong demand in young patients, but it poses high requirements for surgical procedures.

Robot precision surgery has improved the original therapeutic effect. Ye Dingwei said that the previous guidelines for prostate cancer surgery were based on the physical signs of the Western population and were not entirely applicable to the Chinese population. The prostate gland is deeply embedded at the bottom of the human pelvis. Compared to European and American populations, the pelvis of Chinese men presents a "deep toilet" structure, with the prostate gland located narrower and deeper, and the surgical operation space is small and difficult.

How to better apply robot precision surgery to the Chinese population? Ye Dingwei led a team to develop a highly suitable prostate cancer radical surgery "re swelling technique" for the Chinese population based on the structural characteristics of the Chinese pelvis. Through key surgical steps, the maximum tumor eradication is achieved, ensuring patient functional recovery and postoperative safety, and improving patient survival rate and quality of life together.

With the installation and clinical use of multiple fourth generation da Vinci robots in the center, as well as the addition of domestic surgical robots in clinical research, Ye Dingwei was the first to promote the "big version upgrade" of the robot surgical system under ultra fine dissection, that is, the 2.0 version of the re swelling technique based on the precision robot surgical system.

With the dual upgrade of "operating system+artificial intelligence hardware", a single center of a cancer hospital completes nearly a thousand radical surgeries for early-stage prostate cancer patients every year, of which more than 90% of patients undergo nerve preserving radical surgery.

Professor Patel, President of the Global Robotics Surgery Association and Director of Robotics Surgery at the University of Central Florida in the United States, who participated in the summit forum series of activities, commented that the efficiency and accuracy of prostate cancer surgery at Fudan University Affiliated Cancer Hospital have greatly improved, with surgery time reduced by at least 40%, greatly reducing the incidence of surgical complications and maximizing the protection of patient function.

It is reported that robot surgery in tumor hospital is not only used for precise surgery of prostate cancer, but also widely used for surgical treatment of kidney cancer and bladder cancer. The establishment of the Shanghai Institute of Urology and Oncology Robot Surgery Innovation Center will continue to promote the application and development of robot surgery in urology and oncology, reserve outstanding talents in the discipline, promote interaction and exchange between disciplines, create an open technology system, and focus on new concepts, technologies, and other aspects to play a great role in promoting.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended